Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChAd63 ME-TRAP and MVA ME-TRAP in Burkinabe Infants
NCT01635647Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Nov 2012
- Primary completion
- Aug 2014
- Modality
- Viral Vector Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of ChAd63 ME-TRAP, MVA ME-TRAP in malaria, sponsored by University of Oxford. Started Nov 2012; status: completed.
02
Drugs
ChAd63 ME-TRAPMVA ME-TRAP
03
Conditions
malaria
Beyond the preview
Go deeper on NCT01635647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01635647.